We rank companies based on fund manager, research analyst and news sentiment
ATAI stock icon

ATAI Life Sciences
ATAI

$1.87
3.78%
 

About: ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

Employees: 83

0
Funds holding %
of 6,474 funds
0
Analysts bullish %
of 5 analysts
0
News positive %
of 8 articles

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

1,190% more call options, than puts

Call options by funds: $92.8K | Put options by funds: $7.19K

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

0.79% less ownership

Funds ownership: 8.76% [Q3] → 7.98% (-0.79%) [Q4]

1% less capital invested

Capital invested by funds: $18.9M [Q3] → $18.7M (-$250K) [Q4]

11% less funds holding

Funds holding: 93 [Q3] → 83 (-10) [Q4]

15% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 20

37% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 27

Research analyst outlook

5 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$6
221%
upside
Avg. target
$16.2
766%
upside
High target
$20
970%
upside

5 analyst ratings

positive
100%
neutral
0%
negative
0%
Maxim Group
Jason McCarthy
221%upside
$6
Buy
Upgraded
3 Apr 2024
HC Wainwright & Co.
Patrick Trucchio
702%upside
$15
Buy
Maintained
3 Apr 2024
HC Wainwright & Co.
Patrick Trucchio
970%upside
$20
Buy
Maintained
27 Mar 2024
HC Wainwright & Co.
Patrick Trucchio
970%upside
$20
Buy
Reiterated
4 Jan 2024
HC Wainwright & Co.
Patrick Trucchio
970%upside
$20
Buy
Reiterated
2 Jan 2024

Financial journalist opinion

Based on 8 articles about ATAI published over the past 30 days